By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Miscellaneous anxiolytics, sedatives and hypnotics > Dexmedetomidine (buccal/sublingual) > Dexmedetomidine Dosage
Miscellaneous anxiolytics, sedatives and hypnotics
https://themeditary.com/dosage-information/dexmedetomidine-dosage-11143.html

Dexmedetomidine Dosage

Drug Detail:Dexmedetomidine (buccal/sublingual) (Dexmedetomidine (buccal/sublingual) [ dex-med-e-toe-mi-deen ])

Drug Class: Miscellaneous anxiolytics, sedatives and hypnotics

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Usual Adult Dose for Sedation

Intensive Care Unit Sedation:

  • Initial Dose: Loading dose of 1 mcg/kg IV infusion over 10 minutes.
  • Maintenance Dose: 0.2 to 0.7 mcg/kg/hour IV infusion; adjust the infusion rate to achieve the desired clinical effect.

Procedural Sedation:
  • Initial Dose (including Awake Fiberoptic Intubation): 1 mcg/kg IV infusion over 10 minutes.
  • Maintenance Dose: Initiate IV infusion at 0.6 mcg/kg/hour and titrate to achieve the desired clinical effect; doses may range from 0.2 to 1 mcg/kg/hour.

Uses: Sedation of initially intubated and mechanically ventilated patients during treatment in an intensive care setting; sedation of non-intubated patients prior to and/or during surgical and other procedures.

Usual Geriatric Dose for Sedation

Over Age 65 Years:
Intensive Care Unit Sedation: Dose reduction may be required; however, no specific guidelines have been suggested.

Procedural Sedation:

  • Initial Dose: May be omitted or reduced (e.g., 0.5 mcg/kg IV infusion over 10 minutes).
  • Maintenance Dose: Dose reduction may be required; however, no specific guidelines have been suggested.

Uses: Sedation of initially intubated and mechanically ventilated patients during treatment in an intensive care setting; sedation of non-intubated patients prior to and/or during surgical and other procedures.

Renal Dose Adjustments

Data not available.

Liver Dose Adjustments

Dose reduction may be required; however, no specific guidelines have been suggested.

Dose Adjustments

  • Intensive Care Unit Sedation: A loading dose may not be required for patients being converted from alternate sedative therapy.
  • Procedural Sedation Initial Dose: 0.5 mcg/kg IV infusion given over 10 minutes may be suitable for less invasive procedures (e.g., ophthalmic surgery).
  • Maintenance Dose for Awake Fiberoptic Intubation: 0.7 mcg/kg/hour IV infusion until the endotracheal tube is secured.
  • Concomitant Use with other Anesthetics, Sedatives, Hypnotics, or Opioids: Dose reduction may be required; however, no specific guidelines have been suggested.

Precautions

Safety and efficacy have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available.

Other Comments

Administration Advice:

  • Individualize dosing.
  • Administer using a controlled infusion device.
  • Administration by continuous infusion should not exceed 24 hours.
  • Perform regular assessments if this drug is used for more than 14 days.
  • Consider lubricating patients' eyes during drug administration to avoid corneal dryness caused by drug-related lacrimation reduction.
  • It is not necessary to discontinue this drug prior to extubation.
  • Use administration components made with synthetic or coated natural rubber gaskets since there is potential for absorption of this drug to some types of natural rubber.

Reconstitution/Preparation Techniques:
  • Consult the manufacturer product information.

IV Compatibility:
  • Consult the manufacturer product information.

General:
  • In addition to its sedative effects, this drug has a sympatholytic effect, analgesic and anesthetic/analgesic-sparing effects.
  • Avoid using this drug as an induction agent for intubation or for sedation during muscle relaxant use.
  • Avoid using this drug for obstetrics, including caesarean section deliveries, as the safety of this drug in labor and delivery has not been studied.
  • This drug is not suitable in patients who require continuous deep sedation or with severe cardiovascular instability.
  • This drug has not been shown to be amnestic.

Monitoring:
  • Continuously monitor ECG, blood pressure, heart rate, and oxygen saturation levels during infusion and afterwards as clinically appropriate.
Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by